IBDEI1YR ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,33328,0)
 ;;=L56.3^^131^1669^268
 ;;^UTILITY(U,$J,358.3,33328,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33328,1,3,0)
 ;;=3^Solar Urticaria
 ;;^UTILITY(U,$J,358.3,33328,1,4,0)
 ;;=4^L56.3
 ;;^UTILITY(U,$J,358.3,33328,2)
 ;;=^5009217
 ;;^UTILITY(U,$J,358.3,33329,0)
 ;;=L57.0^^131^1669^12
 ;;^UTILITY(U,$J,358.3,33329,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33329,1,3,0)
 ;;=3^Actinic Keratosis
 ;;^UTILITY(U,$J,358.3,33329,1,4,0)
 ;;=4^L57.0
 ;;^UTILITY(U,$J,358.3,33329,2)
 ;;=^66900
 ;;^UTILITY(U,$J,358.3,33330,0)
 ;;=L60.0^^131^1669^161
 ;;^UTILITY(U,$J,358.3,33330,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33330,1,3,0)
 ;;=3^Ingrowing Nail
 ;;^UTILITY(U,$J,358.3,33330,1,4,0)
 ;;=4^L60.0
 ;;^UTILITY(U,$J,358.3,33330,2)
 ;;=^5009234
 ;;^UTILITY(U,$J,358.3,33331,0)
 ;;=L60.1^^131^1669^234
 ;;^UTILITY(U,$J,358.3,33331,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33331,1,3,0)
 ;;=3^Onycholysis
 ;;^UTILITY(U,$J,358.3,33331,1,4,0)
 ;;=4^L60.1
 ;;^UTILITY(U,$J,358.3,33331,2)
 ;;=^186837
 ;;^UTILITY(U,$J,358.3,33332,0)
 ;;=L60.2^^131^1669^233
 ;;^UTILITY(U,$J,358.3,33332,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33332,1,3,0)
 ;;=3^Onychogryphosis
 ;;^UTILITY(U,$J,358.3,33332,1,4,0)
 ;;=4^L60.2
 ;;^UTILITY(U,$J,358.3,33332,2)
 ;;=^5009235
 ;;^UTILITY(U,$J,358.3,33333,0)
 ;;=L60.3^^131^1669^170
 ;;^UTILITY(U,$J,358.3,33333,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33333,1,3,0)
 ;;=3^Nail Dystrophy
 ;;^UTILITY(U,$J,358.3,33333,1,4,0)
 ;;=4^L60.3
 ;;^UTILITY(U,$J,358.3,33333,2)
 ;;=^5009236
 ;;^UTILITY(U,$J,358.3,33334,0)
 ;;=L60.4^^131^1669^88
 ;;^UTILITY(U,$J,358.3,33334,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33334,1,3,0)
 ;;=3^Beau's Lines
 ;;^UTILITY(U,$J,358.3,33334,1,4,0)
 ;;=4^L60.4
 ;;^UTILITY(U,$J,358.3,33334,2)
 ;;=^5009237
 ;;^UTILITY(U,$J,358.3,33335,0)
 ;;=L60.5^^131^1669^290
 ;;^UTILITY(U,$J,358.3,33335,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33335,1,3,0)
 ;;=3^Yellow Nail Syndrome
 ;;^UTILITY(U,$J,358.3,33335,1,4,0)
 ;;=4^L60.5
 ;;^UTILITY(U,$J,358.3,33335,2)
 ;;=^5009238
 ;;^UTILITY(U,$J,358.3,33336,0)
 ;;=L60.8^^131^1669^168
 ;;^UTILITY(U,$J,358.3,33336,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33336,1,3,0)
 ;;=3^Nail Disorders NEC
 ;;^UTILITY(U,$J,358.3,33336,1,4,0)
 ;;=4^L60.8
 ;;^UTILITY(U,$J,358.3,33336,2)
 ;;=^5009239
 ;;^UTILITY(U,$J,358.3,33337,0)
 ;;=L62.^^131^1669^169
 ;;^UTILITY(U,$J,358.3,33337,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33337,1,3,0)
 ;;=3^Nail Disorders in Diseases Classified Elsewhere
 ;;^UTILITY(U,$J,358.3,33337,1,4,0)
 ;;=4^L62.
 ;;^UTILITY(U,$J,358.3,33337,2)
 ;;=^5009241
 ;;^UTILITY(U,$J,358.3,33338,0)
 ;;=L64.9^^131^1669^33
 ;;^UTILITY(U,$J,358.3,33338,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33338,1,3,0)
 ;;=3^Androgenic Alopecia,Unspec
 ;;^UTILITY(U,$J,358.3,33338,1,4,0)
 ;;=4^L64.9
 ;;^UTILITY(U,$J,358.3,33338,2)
 ;;=^5009249
 ;;^UTILITY(U,$J,358.3,33339,0)
 ;;=L65.9^^131^1669^231
 ;;^UTILITY(U,$J,358.3,33339,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33339,1,3,0)
 ;;=3^Nonscarring Hair Loss,Unspec
 ;;^UTILITY(U,$J,358.3,33339,1,4,0)
 ;;=4^L65.9
 ;;^UTILITY(U,$J,358.3,33339,2)
 ;;=^5009252
 ;;^UTILITY(U,$J,358.3,33340,0)
 ;;=L70.0^^131^1669^6
 ;;^UTILITY(U,$J,358.3,33340,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33340,1,3,0)
 ;;=3^Acne Vulgaris
 ;;^UTILITY(U,$J,358.3,33340,1,4,0)
 ;;=4^L70.0
 ;;^UTILITY(U,$J,358.3,33340,2)
 ;;=^5009268
 ;;^UTILITY(U,$J,358.3,33341,0)
 ;;=L70.1^^131^1669^1
 ;;^UTILITY(U,$J,358.3,33341,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33341,1,3,0)
 ;;=3^Acne Conglobata
